Crossmark

FNF-12, a novel benzylidene-chromanone derivative, attenuates inflammatory response in in vitro and in vivo asthma models mediated by M2-related Th2 cytokines via MAPK and NF-kB signaling

Crossref DOI link: https://doi.org/10.1007/s43440-021-00325-0

Published Online: 2021-09-01

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abohassan, Mohammad

Al Shahrani, Mesfer

Alshahrani, Mohammad Y.

Begum, Naseem

Radhakrishnan, Suresh

Rajagopalan, Prasanna http://orcid.org/0000-0001-7593-7234
Funding

Funding for this research was provided by:

Deanship of Scientific Research at King Khalid University (R.G.P.1/265/42.)
License Information

Text and Data Mining valid from 2021-09-01

Version of Record valid from 2021-09-01
More Information

Article History

Received: 22 March 2021

Revised: 2 August 2021

Accepted: 23 August 2021

First Online: 1 September 2021

Declarations

:

: The authors declare that there is no conflict of interest related to this study.

Document is current

Any future updates will be listed below